» Articles » PMID: 31509690

One Month of Rifapentine Plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2019 Sep 12
PMID 31509690
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials.

Assefa D, Bedru A, Zeleke E, Negash S, Debela D, Molla W Arch Public Health. 2023; 81(1):82.

PMID: 37143101 PMC: 10161529. DOI: 10.1186/s13690-023-01098-z.


New developments in tuberculosis diagnosis and treatment.

Gill C, Dolan L, Piggott L, McLaughlin A Breathe (Sheff). 2022; 18(1):210149.

PMID: 35284018 PMC: 8908854. DOI: 10.1183/20734735.0149-2021.


Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.

Burel J, Singhania A, Dubelko P, Muller J, Tanner R, Parizotto E Tuberculosis (Edinb). 2021; 131:102127.

PMID: 34555657 PMC: 8629963. DOI: 10.1016/j.tube.2021.102127.